Patents by Inventor Andre Lee Pearson

Andre Lee Pearson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL ANTIBACTERIAL AGENTS FOR THE TREATMENT OF GRAM POSITIVE INFECTIONS
    Publication number: 20150337013
    Abstract: The present invention relates to novel lipopeptide compounds, pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The compounds of the invention are particularly useful against a variety of bacteria, including resistant strains. The compounds are useful as antibacterial agents against Clostridium difficile.
    Type: Application
    Filed: August 4, 2015
    Publication date: November 26, 2015
    Applicant: Merck Sharp & Dohme Corp.
    Inventors: Chester A. Metcalf, III, Jing Li, Andre Lee Pearson
  • Cephalosporin compound
    Patent number: 8809314
    Abstract: The cephalosporin compound of formula (I) is disclosed, which exhibits antibiotic activity against Gram-negative (e.g., Pseudomonas aeruginosa) and Gram-positive (e.g., methicillin-resistant Staphylococcus aureus) bacteria. Methods of manufacturing the compound of formula (I), and uses of the compound in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.
    Type: Grant
    Filed: September 6, 2013
    Date of Patent: August 19, 2014
    Assignee: Cubist Pharmacueticals, Inc.
    Inventors: Yong He, Yu Gui Gu, Ning Yin, Dong Zou, Andre Lee Pearson
  • NOVEL ANTIBACTERIAL AGENTS FOR THE TREATMENT OF GRAM POSITIVE INFECTIONS
    Publication number: 20140073558
    Abstract: The present invention relates to novel lipopeptide compounds, pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The compounds of the invention are particularly useful against a variety of bacteria, including resistant strains. The compounds are useful as antibacterial agents against Clostridium difficile.
    Type: Application
    Filed: June 12, 2013
    Publication date: March 13, 2014
    Applicant: CUBIST PHARMACEUTICALS, INC.
    Inventors: Chester A. Metcalf, III, Jing Li, Andre Lee Pearson
  • Antibacterial agents for the treatment of gram positive infections
    Patent number: 8507647
    Abstract: The present invention relates to novel lipopeptide compounds, pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The compounds of the invention are particularly useful against a variety of bacteria, including resistant strains. The compounds are useful as antibacterial agents against Clostridium difficile.
    Type: Grant
    Filed: December 18, 2009
    Date of Patent: August 13, 2013
    Assignee: Cubist Pharmaceuticals, Inc.
    Inventors: Chester A. Metcalf, III, Jing Li, Andre Lee Pearson
  • NOVEL ANTIBACTERIAL AGENTS FOR THE TREATMENT OF GRAM POSITIVE INFECTIONS
    Publication number: 20100184649
    Abstract: The present invention relates to novel lipopeptide compounds, pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The compounds of the invention are particularly useful against a variety of bacteria, including resistant strains. The compounds are useful as antibacterial agents against Clostridium difficile.
    Type: Application
    Filed: December 18, 2009
    Publication date: July 22, 2010
    Inventors: Chester A. MetCalf, III, Jing Li, Andre Lee Pearson